Myasthenia


Also found in: Dictionary, Thesaurus, Medical, Financial, Wikipedia.
Related to Myasthenia: Ocular myasthenia

myasthenia

[‚mī·əs·thēn·ē·ə]
(medicine)
Muscular weakness.

Myasthenia

 

(asthenic bulbar paralysis, asthenic ophthalmoplegia, pseudobulbar paralysis, Erb-Goldflam disease), a neuromuscular disease characterized by the pathological, rapid fatigability of striated muscles.

The onset of myasthenia usually occurs between the ages of 20 and 40 years; women are more frequently affected, Autoimmune processes play a part in the development of the disease; antibodies have been discovered in muscle tissue and in the thymus gland. The muscles of the eyelids are often affected and there is ptosis, which varies in degree during the day; the masticatory muscles are affected, swallowing is disrupted, and the gait changes. Treatment includes anticholinesterase preparations, vitamins (especially B-group), general restorative treatment, and sometimes the removal of the thymus gland.

REFERENCES

Lobzin, V. S. Miasteniia. Leningrad, 1960.
Shefer, D. G. Gipotalamicheskie (dientsefal’nye) sindromy, 2nd ed. Moscow, 1971.
References in periodicals archive ?
Coronary artery bypass surgery in a patient with myasthenia gravis.
Apart from anything else a myasthenia nurse can help to avoid episodes escalating, resulting in unnecessary hospital visits.
Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase.
Our patient previously received a thymectomy as treatment for her myasthenia gravis disease and developed myeloid sarcoma in her right acetabulum 17 years later without ever displaying any signs of leukemia.
Many dogs with myasthenia gravis eventually go through remission, sometimes within months of the initial diagnosis.
of Buffalo), Meriggioli, Ciafaloni, and Ruff collect 19 papers from the 12th International Conference on Myasthenia Gravis and Related Disorders, held in May 2012 in New York City.
An estimated 8,000 people across the UK have myasthenia gravis, and 6,000 of those are known to the charity.
We are pleased to receive this award which affords us the opportunity to further investigate CK-2017357 as a potential treatment for patients with myasthenia gravis.
Myasthenia gravis (MG) [1] is a well-characterized autoimmune disease with an estimated prevalence of 1 in 5000 individuals (1).
The trek is to raise awareness and funds for Myasthenia Gravis, an auto-immune disease.
In written reply, the health minister told the House that neither any case of Myasthenia Gravis has yet been reported nor any report regarding use of spurious drugs in treatment of the disease has been received.